Latest Piperazines Stories
Trial is the first to study schizophrenia treatment within the context of many real-world issues faced by patients with schizophrenia TITUSVILLE, N.J., April 15, 2015 /PRNewswire/ -- A study
DeepResearchReports.com adds "Global and China Olanzapine Industry 2015 Research Report" , "2015 Global Quetiapine Fumarate Industry Report" and "Global Montelukast Sodium Industry 2015 - 2020" Research
Results served as basis for regulatory filing with U.S.
Coalition highlights momentum behind campaign for approval of first-ever drug for women's sexual dysfunction, launches new website for supporters to contact their elected representatives
- Treatment for Major Depressive Disorder (MDD) in Adults- DUBLIN, March 16, 2015 /PRNewswire/ -- Actavis plc (NYSE: ACT) today announced the U.S.
BRISTOL, Tenn., March 4, 2015 /PRNewswire/ -- UPM Pharmaceuticals, a division of Gregory Pharmaceutical Holdings, Inc., has reached an agreement with Sprout Pharmaceuticals to manufacture Flibanserin
EAST SETAUKTET, N.Y., Feb. 25, 2015 /PRNewswire/ -- Lixte Biotechnology Holdings Inc.
RALEIGH, N.C., Feb. 17, 2015 /PRNewswire/ -- Sprout Pharmaceuticals announced today that it has resubmitted a New Drug Application (NDA) to the U.S.
RnRMarketResearch.com adds "Otitis Media - Pipeline Review, H1 2015" report to its store. The report provides an overview of the Otitis Media's therapeutic pipeline. DALLAS, Feb.
LEXINGTON, Massachusetts, January 26, 2015 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPG) announces that the United States Food and Drug Administration (FDA) has granted
- Stoppage; cessation (of labor).
- A standing still or idling (of mills, factories, etc.).